Rocket ... Similar emotions. It was exciting to see the Covid trial finally start dosing and get started, and there seems to be solid enthusiasm and a belief that the data will be good. But history, finances, debenture, etc., and all things considered, I have retrained myself (along with the rest of the world) to wait and see results and a plan rather than a forward looking "vision." I was excited to see the initial pps jumps from starting the trial, but sure as the sun coming up we gave it back rather than solidifying some traction and sustainable momentum. Although it is a VERY small sample size of a few days. Let's just hope this trial goes quickly, we have good results, and acquire emergency relief acceleration! 

I would not want to be an RVX short player right now though. Just not a very far distance to go down, and a lot of room to go up ... unless you are short betting on trial failure and the debenture (IP risk) looming, I guess?

Good luck to RVX with this trial!